| DON'T BUY | 2.420 | Benj Gallander | This is on his Stock Watch list. Balance sheet is pretty dirty with a lot of debt. Company is trying to make major changes, but at this point the risk is far too great for him. Likes the field, which is a growing one. | 2007-12-24 | |
| WATCH | 6.150 | Bill Carrigan | May have reached its bottom in August. Check the volume from that point. In order to have a bottom, you want 3 X the average volume, a rally and then a correction. If it does not make a new low, that is your signal to buy. | 2006-09-15 | |
| DON'T BUY | 6.070 | David Driscoll | Doesn't see anything in the metrics that makes it appealing. Too risky. Has a lot of competition. | 2006-09-14 | |
| WEAK BUY | 6.090 | Brian Acker, CA | His problem with the stock is that there is only one estimate, so the information given may not be that good. The model price shows as $9.90, a 65% positive differential. Be cautious | 2006-08-31 | |
| DON'T BUY | 5.840 | Peter Hodson | Doing very poorly against their US competitor LCA Vision (LCAV-Q). Also had problems with their subsidiary Occulogix when their clinical trial failed. Starting to get beaten up enough to maybe start paying attention to it. | 2006-08-28 | |
| DON'T BUY | 6.120 | Robert Floyd | The real problem has been the irregularity of their earnings. Don't seem to have quarterly momentum in their financials. Increasing competition. | 2006-08-18 | |
| SELL | 7.340 | Ron Meisels | Below its 200 day moving average and just recently hit a new low. | 2005-10-17 | |
| WEAK BUY | 10.930 | Brian Acker, CA | Expensive. Model price is $13.08, so there is a discount and value. Trades at a high multiple to book. If they ever stumble it would sink like a stone. | 2005-06-09 | |
| DON'T BUY | 10.100 | Peter Hodson | Also owns a US company LCA Vision (LCAV-Q) and have been selling his TLC shares to buy LCA. Feels LCA is a better run company on the laser vision procedures. | 2005-05-10 | |
| VAGUE | 10.770 | Bill Carrigan | The chart looks like it's trying to form a base. Don't let it make a 52 week low on you. If there is an oil shock and rates go up, it could hurt. | 2005-03-15 | |
| DON'T BUY | 12.750 | Gavin Graham | Has been a pretty bumpy ride and still well down from where they were 4/5 years ago. The merger with OccuLogix seems to be a sensible deal. On a 4/5 year basis it is probably going to end up as one of the consolidators. Not sure they will make enough money to make it worthwhile. | 2004-12-13 | |
| BUY | 14.530 | Ron Meisels | Got up to $17 this year and had a correction. Has stayed in the $10/12 area for several months. It is now starting a new upleg. Just went above its 200 day moving average. | 2004-12-01 | |
| BUY on WEAKNESS | 14.530 | Brian Acker, CA | Model price is $31.25, so fully priced. Seems to go through a boom/bust cycle twice a year. | 2004-11-30 | |
| PAST TOP PICK | 10.800 | Ron Meisels | (A Top Pick Mar 17/04. Down 26%.) Sold out near its top in May. Coming back to a support level at around $10 and could be a chance to buy it back. | 2004-08-24 | |
| BUY | 13.900 | Michael Smedley | Has dropped because there will be a delay in spinning off its Rheopheresis blood filtration process. Interesting speculation. Fundamentals have been improving so it looks good at this price. | 2004-05-12 | |
| PAST TOP PICK | 17.500 | Ron Meisels | (A top pick Mar 17/04. Up 17%.) Still likes. Haven't gone very far from the breakout of the base, so that expects more. | 2004-04-23 | |
| TOP PICK | 14.930 | Ron Meisels | Has established a strong base and is out of favor. Has now started a new up leg. Waiting for a pullback to $13 to buy. | 2004-03-17 | |
| BUY on WEAKNESS | 12.300 | Bruce Campbell | Laser eye treatments are starting a turnaround with newer techniques. FDA approval on a new drug for macular degeneration could make laser treatment a small part. | 2004-01-27 | |
| DON'T BUY | 8.420 | David Baskin | Probably fully priced and competition can easily be built up. | 2003-09-29 | |
| PAST TOP PICK | 8.200 | Peter Hodson | (Was a top pick July 29/03. Down 9.43 to 8.18%) Competition upped their guidance by 50%, which put a damper on the stock. Still likes. | 2003-09-09 | |
| TOP PICK | 9.430 | Peter Hodson | Most of their problems have been eliminated. Costs have decreased and revenues have increased. Competition is limited. Great balance sheet. | 2003-07-29 | |
| WATCH | 4.750 | Lou Schizas | Have diversified their income stream. Revenue is up. Earnings have gone up to $0.01 a share. Hit a double bottom in October and March and then took off. Watch for the $6 level to see if it can break through or is a drop. | 2003-05-27 | |
| DON'T BUY | 1.860 | Rob Peets | To have growth potential, new products will be needed. | 2003-01-28 | |
| DON'T BUY | 2.790 | David Baskin | Demand for laser eye surgery may be down. | 2002-10-31 | |
| DON'T BUY | 5.610 | Robert Floyd | Has a lot of competition. Before buying, would like to see some growth built out. | 2002-04-05 | |
| WEAK BUY | 5.250 | Martin Hubbes, CFA | A lot of competition has gone under so its better now, but can only see limited upside. | 2002-03-06 | |
| DON'T BUY | 4.200 | Bruce Cooper | In a tough business. Has lost money for the last 8 years. Has a lot of competition. | 2002-01-15 | |
| DON'T BUY | 4.950 | Robert Floyd | Have to watch for the strength of the balance sheet. | 2001-11-22 | |
| DON'T BUY | 5.760 | John Sinkins, CFA | Merger will be good. Still a growth stock, but not as robust. Wait for merger to settle in. | 2001-08-29 | |
| BUY | 7.380 | Steven Wippersteg | Good turnaround. Likes what they are doing. Good price. | 2001-07-30 | |
| DON'T BUY | 6.600 | Bruce Cooper | A tough business. Too much competition. | 2001-06-07 | |
| DON'T BUY | 6.360 | John Sinkins, CFA | Will have to increase sales and have a price increase. | 2001-06-06 | |
| DON'T BUY | 8.250 | Bruce Campbell | Starting to recover, but is fully valued now. | 2001-05-28 | |
| DON'T BUY | 8.020 | Ross Healy | Not a fan. | 2001-05-03 | |
| DON'T BUY | 11.500 | Ted Macklin | Technology changes rapidly and cost structure is a question. Is night vision a potential problem in the future? | 2001-04-11 | |
| DON'T BUY | 11.800 | David Driscoll | Doesn't like the business model. | 2001-03-16 | |
| DON'T BUY | 14.100 | Brian Acker, CA | May win out over the competition. Have to wait and see. | 2001-03-08 | |
| DON'T BUY | 8.900 | Mark Bonham | Not a fan | 2001-02-16 | |
| BUY | 9.450 | Gavin Graham | Expects some mergers. Has a good balance sheet and fundamentals are good. | 2001-02-15 | |
| BUY | 9.550 | Pierre Bernard | This sector benefiting from aging population with lots of money. Good managers. Expect mergers/consolidations/acquisitions. | 2001-02-13 | |
| DON'T BUY | 5.000 | Glenn Paradis, BA, CFA | An acquisition target? | 2001-02-01 | |
| DON'T BUY | 5.730 | Ted Macklin | A lot of competition | 2001-01-29 | |
| DON'T BUY | 2.600 | Rob Callander | Too many problems with competition & Gov't warnings | 2000-12-21 | |
| DON'T BUY | 3.000 | Keith Graham | Debt problem and less margin now | 2000-12-12 | |
| WAIT | 3.150 | Ed Ho | Trying to market at a high price but competition charge less. In process of acquiring eye clinics to expand | 2000-12-11 | |
| DON'T BUY | 5.000 | Brendan Kyne | Too much competition. Probably at its low, but margins are thin | 2000-11-16 | |
| DON'T BUY | 5.000 | Ross Healy | Turning into an orphan stock, I.e., unloved and unfollowed | 2000-10-19 | |
Experts that have talked about TLC Laser Eye Centres
Rss Top Picks Feed
